Abstract
From the historical point of view it would appear that right from the beginning of the era that we call modern medicine, drugs have been regarded as important tools in elucidating the biochemi cal pathology of disease. In the history of Parkinson’s disease there has been hardly a drug that has not been tried as a potential remedy. The long list includes such oddities as ferrisulfate, barium chloride, strychnine, metrazol, thyroid and parathyroid hormones, and — surprizingly — striaphorin, an extract of the striatum. Of all the older antiparkinson drugs, anticholinergics attained special significance because of their unquestionable (though low) therapeutic efficacy. However, these drugs also led the thinking of researchers astray because for a long time the effectiveness of the anticholinergic agents was taken as evidence that Parkinson’s disease may be primarily a disorder of cholinergic brain mechanisms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andén, N.-E. (1974). Inhibition of the turnover of the brain dopamine after treatment with the gamma-aminobutyrate:2-oxyglutarate transaminase inhibitor aminooxyacetic acid. Arch Pharmacol. 283 ,419–424.
Barbeau, A., Sourkes, T.L. and Murphy, G. (1962). Les catecholamines dans la maladie de Parkinson. In Monoamines et System Nerveux Central (Ajuriaguerra, J.de, Ed.) pp. 247–262. Georg, Geneva and Masson, Paris.
Barolin, G.S., Bernheimer, H. and Hornykiewicz, O. (1964). Seiten verschiedenes Verhalten des Dopamins (3-Hydroxytyramin) im Gehirn eines Falles von Hemiparkinsonismus. Schweiz. Arch. Neurol. Psychûzt. 94 ,241–248.
Bartholini, G., Stadler, H. and Lloyd, K.G. (1975). Cholinergic dopaminergic interregulations within the extrapyramidal sys tem. In Cholinergic Mechanisms (Waser, P.G., Ed.) pp. 411–418. Raven Press, New York.
Bernheimer, H. and Hornykiewicz, O. (1962). Das Verhalten einiger Enzyme im Gehirn normaler und Parkinsonkranker Menschen. Arch. exp. Path. Pharmak. 243 ,295.
Bernheimer, H. and Hornykiewicz, O. (1965). Herabgesetzte Konzentration der homovanillinsäure im Gehirn von Parkinsonkranken Menschen als Ausdruck der Störung des zentralen Dopaminstoff wechsels. Klin.Wschr. 43 ,711–715.
Bernheimer, H., Birkmayer, W. and Hornykiewicz, O. (1961). Verteilung des 5-Hydroxytryptamins (Serotonin) im Gehirn des Menschen und sein Verhalten bei Patienten mit Parkinson-Syndrom. Klin. Wschr. 39 ,1056–1059.
Bernheimer, H., Birkmayer, W. and Hornykiewicz, O. (1963). Zur Biochemie des Parkinson-Syndroms des Menschen. Klin. Wschr. 41 ,465–469.
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. and Seitelberger, F. (1973). Brain dopamine and the syndromes of Parkinson and Huntington. J. Neurol. Sci. 20 ,415–455.
Bertler, A. and Rosengren, E. (1959). Occurrence and distribution of dopamine in brain and other tissues. Experientia 15 ,10–11.
Birkmayer, W. and Hornykiewicz, O. (1961). Der L-Dioxyphenylalanin (= L-D0PA)-Effekt bei der Parkinson-Akinese. Wien.Klin. Wschr. 73 ,787–788.
Carlsson, A. (1959). The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol. Rev. 11 ,490–493.
Carlsson, A., Lindqvist, M. and Magnusson, T. (1957). 3,4-Dihydroxy phenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180 ,1200.
Carlsson, A., Lindqvist, M., Magnusson, T. and Waldeck, B. (1958). On the presence of 3-hydroxytyramine in brain. Science 127 ,471.
Cotzias, G.C., Van Woert, M.H. and Schiffer, L.M. (1967). Aromatic amino acids and modification of parkinsonism. New Engl. J. Meä. 276 ,374–379.
Ehringer, H. and Hornykiewicz, O. (1960). Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin.Wschr. 38 ,1236–1239.
Farley, I.J. and Hornykiewicz, O. (1977). Noradrenaline in subcortical brain regions of patients with Parkinson’s disease and control subjects. In Advances in Parkinsonism, Biochem istry, Physiology, Treatment (Birkmayer, W. and Hornykiewicz, O., Eds.) Editiones Roche, Basel (in press).
Farley, I.J., Price, K.S. and Hornykiewicz, O. (1977). Dopamine in the limbic regions of the human brain: normal and abnormal. In Advances in Biochem. Psychopharmacol. vol. 16 (Costa, E. and Gessa, G.L., Eds.) pp. 57–64. Raven Press, New York.
Fuxe, K., Hökfelt, T. and Ungerstedt, U. (1970). Morphological and functional aspects of central monoamine neurons. Int. Rev. Neurobiol. 13 ,93–126.
Grabowska, M. and Michaluk, J. (1974). On the role of serotonin in apomorphine-induced locomotor stimulation in rats. Pharmacology, Biochemistry and Behavior 2 ,263–266.
Hollister, A.S., Breese, G.R., Kuhn, C.M., Cooper, B.R. and Shanberg, S.M. (1975). Evidence for an inhibitory function of brain serotonin systems in the locomotor stimulant effects of D-amphetamine. Neurosci. Abstr. 1 ,297.
Hornykiewicz, O. (1963). Die topische Lokalisation und Verhalten von Noradrenalin und Dopamin (3-Hydroxytyramin) in der Sub stantia nigra des normalen und Parkinsonkranken Menschen. Wien. Klin, W schr. 75 ,309–312.
Hornykiewicz, O. (1976). Neurohumoral interactions and basal ganglia function and dysfunction. In The Basal Ganglia (Yahr, M.D., Ed.) pp. 269–278. Raven Press, New York.
Lahti, R.A. and Losey, E.G. (1974). Antagonism of the effects of chlorpromazine and morphine on dopamine metabolism by GABA. Res. Commun. Chem. Pathol. Pharmacol. 7 ,31–40.
Lloyd, K.G. and Hornykiewicz, O. (1970). Parkinson’s disease: activity of L-DOPA decarboxylase in discrete brain regions. Science 170 ,1212–1213.
Lloyd, K.G. and Hornykiewicz, O. (1973). L-Glutamic acid decarboxylase in Parkinson’s disease: effect of L-dopa therapy. Nature 243 ,521–523.
Lloyd, K.G. and Hornykiewicz, O. (1975). Catecholamines in regulation of motor function. In Catecholamines and Behavior, vol. 1 (Friedhoff, A.J., Ed.) pp. 41–57. Plenum Publ. Comp., New York.
Lloyd, K.G., Davidson, L. and Hornykiewicz, O. (1975). The neurochemistry of Parkinson’s disease: effect of L-dopa therapy. J. Pharmacol. 195 ,453–464.
Maj, J., Pawlowski, L. and Sarnek, J. (1974). The role of brain 5-hydroxytryptamine in the central action of L-DOPA. In Advances in Biochem. Psychopharmacol. vol. 10 (Costa, E., Gessa, G.L. and Sandier, M., Eds.) pp. 253–256. Raven Press, New York.
Nauta, W.J.H. (1977). Some cross-roads of limbic and striatal circuitry. In The Continuing Evolution of the Limbic System Concept (Livingston, K. and Hornykiewicz, O., Eds.). Plenum Press, New York (in press).
Pijnenburg. A.J.J., Honig, W.M.M., Van der Heyden, J.A.M. and Van Rossum, J.M. (1976). Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Europ. J. Pharmacol. 35 ,45–58.
Raab, W. and Gigee, W. (1951). Concentration and distribution of “encephalin” in the brain of humans and animals. Proa. Soc. exp. Bio. 76 ,97–100.
Tarsy, D., Pycock, C., Meldrum, B. and Marsden, C.D. (1975). Rotational behaviour induced in rats by intranigral picrotoxin. Brain Res. 89 ,160–165.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Hornykiewicz, O. (1977). Historical Aspects and Frontiers of Parkinson’s Disease Research. In: Messiha, F.S., Kenny, A.D. (eds) Parkinson’s Disease. Advances in Experimental Medicine and Biology, vol 90. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-2511-6_1
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2511-6_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-2513-0
Online ISBN: 978-1-4684-2511-6
eBook Packages: Springer Book Archive